Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac N.V (CVAC) Interest & Investment Income: 2019-2025

Historic Interest & Investment Income for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to $2.7 million.

  • CureVac N.V's Interest & Investment Income fell 2.73% to $2.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $14.6 million, marking a year-over-year decrease of 13.88%. This contributed to the annual value of $15.0 million for FY2024, which is 16.73% down from last year.
  • Latest data reveals that CureVac N.V reported Interest & Investment Income of $2.7 million as of Q2 2025, which was down 25.92% from $3.6 million recorded in Q1 2025.
  • CureVac N.V's 5-year Interest & Investment Income high stood at $10.1 billion for Q4 2021, and its period low was -$8.8 billion during Q2 2021.
  • Its 3-year average for Interest & Investment Income is $4.2 million, with a median of $3.8 million in 2023.
  • Data for CureVac N.V's Interest & Investment Income shows a peak YoY increase of 279,688.87% (in 2021) and a maximum YoY decrease of 39,935,617.38% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows CureVac N.V's Interest & Investment Income stood at $10.1 billion in 2021, then tumbled by 100.07% to -$6.7 million in 2022, then skyrocketed by 153.30% to $3.6 million in 2023, then surged by 60.26% to $5.8 million in 2024, then declined by 2.73% to $2.7 million in 2025.
  • Its Interest & Investment Income stands at $2.7 million for Q2 2025, versus $3.6 million for Q1 2025 and $5.8 million for Q4 2024.